|
1
|
Parkin DM, Bray F, Ferlay J and Pisani P:
Global cancer statistics, 2002. CA Cancer J Clin. 55:74–108. 2005.
View Article : Google Scholar
|
|
2
|
Venook AP: Treatment of hepatocellular
carcinoma: too many options? J Clin Oncol. 12:1323–1334.
1994.PubMed/NCBI
|
|
3
|
Chen YT, Scanlan MJ, Sahin U, et al: A
testicular antigen aberrantly expressed in human cancers detected
by autologous antibody screening. Proc Natl Acad Sci USA.
94:1914–1918. 1997. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Chen YT, Gure AO, Tsang S, et al:
Identification of multiple cancer/testis antigens by allogeneic
antibody screening of a melanoma cell line library. Proc Natl Acad
Sci USA. 95:6919–6923. 1998. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Wang RF, Johnston SL, Zeng G, Topalian SL,
Schwartzentruber DJ and Rosenberg SA: A breast and melanoma-shared
tumor antigen: T cell responses to antigenic peptides translated
from different open reading frames. J Immunol. 161:3598–3606.
1998.PubMed/NCBI
|
|
6
|
Perez D, Hauswirth F, Jager D, et al:
Protein expression of cancer testis antigens predicts tumor
recurrence and treatment response to imatinib in gastrointestinal
stromal tumors. Int J Cancer. 128:2947–2952. 2011. View Article : Google Scholar
|
|
7
|
Svobodova S, Browning J, Macgregor D, et
al: Cancer-testis antigen expression in primary cutaneous melanoma
has independent prognostic value comparable to that of Breslow
thickness, ulceration and mitotic rate. Eur J Cancer. 47:460–469.
2010. View Article : Google Scholar
|
|
8
|
Chen CH, Chen GJ, Lee HS, et al:
Expressions of cancer-testis antigens in human hepatocellular
carcinomas. Cancer Lett. 164:189–195. 2001. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Luo G, Huang S, Xie X, et al: Expression
of cancer-testis genes in human hepatocellular carcinomas. Cancer
Immun. 2:112002.PubMed/NCBI
|
|
10
|
Korangy F, Ormandy LA, Bleck JS, et al:
Spontaneous tumor-specific humoral and cellular immune responses to
NY-ESO-1 in hepatocellular carcinoma. Clin Cancer Res.
10:4332–4341. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Peng JR, Chen HS, Mou DC, et al:
Expression of cancer/testis (CT) antigens in Chinese hepatocellular
carcinoma and its correlation with clinical parameters. Cancer
Lett. 219:223–232. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Zhang WM, Xiao G, Xie D, Zhang M, Guo AL
and Wen JM: Correlation of NY-ESO-1 gene and protein expression to
metastasis and clinicopathologic features of hepatocellular
carcinoma. Ai Zheng. 24:622–626. 2005.PubMed/NCBI
|
|
13
|
Zhang WM, Xiao G, Zhang M, Guo AL, Dong Y
and Wen JM: Expression of NY-ESO-1 and LAGE-1 cancer-testis
antigens in hepatocellular carcinoma. Zhonghua Bing Li Xue Za Zhi.
34:202–205. 2005.PubMed/NCBI
|
|
14
|
Nakamura S, Nouso K, Noguchi Y, et al:
Expression and immunogenicity of NY-ESO-1 in hepatocellular
carcinoma. J Gastroenterol Hepatol. 21:1281–1285. 2006. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Lu Y, Wu LQ, Lu ZH, Wang XJ and Yang JY:
Expression of SSX-1 and NY-ESO-1 mRNA in tumor tissues and its
corresponding peripheral blood expression in patients with
hepatocellular carcinoma. Chin Med J (Engl). 120:1042–1046.
2007.PubMed/NCBI
|
|
16
|
Wang XY, Chen HS, Luo S, Zhang HH, Fei R
and Cai J: Comparisons for detecting NY-ESO-1 mRNA expression
levels in hepatocellular carcinoma tissues. Oncol Rep. 21:713–719.
2009.PubMed/NCBI
|
|
17
|
Abassi YA, Jackson JA, Zhu J, O’Connell J,
Wang X and Xu X: Label-free, real-time monitoring of IgE-mediated
mast cell activation on microelectronic cell sensor arrays. J
Immunol Methods. 292:195–205. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Perez D, Herrmann T, Jungbluth AA, et al:
Cancer testis antigen expression in gastrointestinal stromal
tumors: new markers for early recurrence. Int J Cancer.
123:1551–1555. 2008. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Konishi J, Toyooka S, Aoe M, et al: The
relationship between NY-ESO-1 mRNA expression and
clinicopathological features in non-small cell lung cancer. Oncol
Rep. 11:1063–1067. 2004.PubMed/NCBI
|
|
20
|
Velazquez EF, Jungbluth AA, Yancovitz M,
et al: Expression of the cancer/testis antigen NY-ESO-1 in primary
and metastatic malignant melanoma (MM)--correlation with prognostic
factors. Cancer Immun. 7:112007.PubMed/NCBI
|
|
21
|
Zhou JX, Li Y, Chen SX and Deng AM:
Expression and prognostic significance of cancer-testis antigens
(CTA) in intrahepatic cholagiocarcinoma. J Exp Clin Cancer Res.
30:22011. View Article : Google Scholar : PubMed/NCBI
|
